
    
      We are now in follow-up to evaluate the medium term and long term outcomes of all 300
      patients originally enrolled in above mentioned randomized clinical trial. The follow-up of
      patients is approved by the Capital Health Research Ethics Board (CDHA-RS/2004-295).
    
  